BALLY'S CORP (BALY) Fundamental Analysis & Valuation

NYSE:BALY • US05875B3042

Current stock price

12.87 USD
-0.15 (-1.15%)
Last:

This BALY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. BALY Profitability Analysis

1.1 Basic Checks

  • BALY had negative earnings in the past year.
  • In the past year BALY has reported a negative cash flow from operations.
  • BALY had negative earnings in each of the past 5 years.
  • Of the past 5 years BALY 4 years had a positive operating cash flow.
BALY Yearly Net Income VS EBIT VS OCF VS FCFBALY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M -600M

1.2 Ratios

  • The Return On Assets of BALY (-6.24%) is worse than 81.75% of its industry peers.
  • With a Return On Equity value of -70.49%, BALY is not doing good in the industry: 69.84% of the companies in the same industry are doing better.
  • The Return On Invested Capital of BALY (0.24%) is worse than 80.16% of its industry peers.
Industry RankSector Rank
ROA -6.24%
ROE -70.49%
ROIC 0.24%
ROA(3y)-6.22%
ROA(5y)-5.43%
ROE(3y)-645.76%
ROE(5y)-399.44%
ROIC(3y)N/A
ROIC(5y)N/A
BALY Yearly ROA, ROE, ROICBALY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K -1.5K

1.3 Margins

  • BALY has a Operating Margin of 1.08%. This is in the lower half of the industry: BALY underperforms 76.98% of its industry peers.
  • In the last couple of years the Operating Margin of BALY has declined.
  • The Gross Margin of BALY (54.84%) is better than 65.87% of its industry peers.
  • BALY's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.08%
PM (TTM) N/A
GM 54.84%
OM growth 3Y-51.97%
OM growth 5Y-26.17%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-2.67%
BALY Yearly Profit, Operating, Gross MarginsBALY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. BALY Health Analysis

2.1 Basic Checks

  • BALY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • BALY has more shares outstanding than it did 1 year ago.
  • BALY has more shares outstanding than it did 5 years ago.
  • BALY has a better debt/assets ratio than last year.
BALY Yearly Shares OutstandingBALY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
BALY Yearly Total Debt VS Total AssetsBALY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • BALY has an Altman-Z score of 0.16. This is a bad value and indicates that BALY is not financially healthy and even has some risk of bankruptcy.
  • BALY has a Altman-Z score of 0.16. This is amonst the worse of the industry: BALY underperforms 85.71% of its industry peers.
  • A Debt/Equity ratio of 4.49 is on the high side and indicates that BALY has dependencies on debt financing.
  • BALY's Debt to Equity ratio of 4.49 is on the low side compared to the rest of the industry. BALY is outperformed by 63.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.49
Debt/FCF N/A
Altman-Z 0.16
ROIC/WACC0.03
WACC8.83%
BALY Yearly LT Debt VS Equity VS FCFBALY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 0.80 indicates that BALY may have some problems paying its short term obligations.
  • BALY's Current ratio of 0.80 is on the low side compared to the rest of the industry. BALY is outperformed by 61.90% of its industry peers.
  • A Quick Ratio of 0.77 indicates that BALY may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.77, BALY is not doing good in the industry: 61.11% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.77
BALY Yearly Current Assets VS Current LiabilitesBALY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. BALY Growth Analysis

3.1 Past

  • The earnings per share for BALY have decreased by -0.51% in the last year.
  • BALY shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.42%.
  • The Revenue has been growing by 48.11% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-0.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-231.25%
Revenue 1Y (TTM)8.42%
Revenue growth 3Y5.61%
Revenue growth 5Y48.11%
Sales Q2Q%28.58%

3.2 Future

  • The Earnings Per Share is expected to grow by 18.62% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 11.45% on average over the next years. This is quite good.
EPS Next Y48.65%
EPS Next 2Y28.41%
EPS Next 3Y18.62%
EPS Next 5YN/A
Revenue Next Year23.73%
Revenue Next 2Y14.22%
Revenue Next 3Y11.45%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BALY Yearly Revenue VS EstimatesBALY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
BALY Yearly EPS VS EstimatesBALY Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -2 -4 -6 -8 -10

More info and screens

Find the best growth stocksShow best growing peers

1

4. BALY Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BALY. In the last year negative earnings were reported.
  • Also next year BALY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BALY Price Earnings VS Forward Price EarningsBALY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as BALY.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.58
BALY Per share dataBALY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 -100

4.3 Compensation for Growth

  • BALY's earnings are expected to grow with 18.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.41%
EPS Next 3Y18.62%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BALY Dividend Analysis

5.1 Amount

  • BALY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BALY Fundamentals: All Metrics, Ratios and Statistics

BALLY'S CORP

NYSE:BALY (4/29/2026, 8:04:00 PM)

12.87

-0.15 (-1.15%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Industry Strength57.76
Industry Growth17.39
Earnings (Last)03-23
Earnings (Next)05-11
Inst Owners78.1%
Inst Owner Change0%
Ins Owners12.92%
Ins Owner Change1.4%
Market Cap627.28M
Revenue(TTM)2.66B
Net Income(TTM)-701.10M
Analysts48
Price Target13.26 (3.03%)
Short Float %2.05%
Short Ratio10.73
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-431.84%
Min EPS beat(2)-649.7%
Max EPS beat(2)-213.99%
EPS beat(4)1
Avg EPS beat(4)-572.32%
Min EPS beat(4)-1443.99%
Max EPS beat(4)18.41%
EPS beat(8)2
Avg EPS beat(8)-687.11%
EPS beat(12)2
Avg EPS beat(12)-699.7%
EPS beat(16)4
Avg EPS beat(16)-676.12%
Revenue beat(2)1
Avg Revenue beat(2)2.18%
Min Revenue beat(2)-1.91%
Max Revenue beat(2)6.27%
Revenue beat(4)1
Avg Revenue beat(4)-0.06%
Min Revenue beat(4)-4.31%
Max Revenue beat(4)6.27%
Revenue beat(8)1
Avg Revenue beat(8)-2.18%
Revenue beat(12)1
Avg Revenue beat(12)-2.31%
Revenue beat(16)1
Avg Revenue beat(16)-2.94%
PT rev (1m)-21.92%
PT rev (3m)-21.92%
EPS NQ rev (1m)-91.75%
EPS NQ rev (3m)-82.7%
EPS NY rev (1m)-143.07%
EPS NY rev (3m)-143.07%
Revenue NQ rev (1m)8.36%
Revenue NQ rev (3m)8.36%
Revenue NY rev (1m)16.2%
Revenue NY rev (3m)16.2%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.24
P/FCF N/A
P/OCF N/A
P/B 0.63
P/tB N/A
EV/EBITDA 12.58
EPS(TTM)-11.77
EYN/A
EPS(NY)-6.04
Fwd EYN/A
FCF(TTM)-6.49
FCFYN/A
OCF(TTM)-1.87
OCFYN/A
SpS54.51
BVpS20.41
TBVpS-111.6
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -6.24%
ROE -70.49%
ROCE 0.3%
ROIC 0.24%
ROICexc 0.26%
ROICexgc 0.98%
OM 1.08%
PM (TTM) N/A
GM 54.84%
FCFM N/A
ROA(3y)-6.22%
ROA(5y)-5.43%
ROE(3y)-645.76%
ROE(5y)-399.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-54.91%
ROICexgc growth 5Y-11.27%
ROICexc growth 3Y-56.99%
ROICexc growth 5Y-21.54%
OM growth 3Y-51.97%
OM growth 5Y-26.17%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-2.67%
F-Score6
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 4.49
Debt/FCF N/A
Debt/EBITDA 12.97
Cap/Depr 71.35%
Cap/Sales 8.47%
Interest Coverage 0.08
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.8
Quick Ratio 0.77
Altman-Z 0.16
F-Score6
WACC8.83%
ROIC/WACC0.03
Cap/Depr(3y)93.34%
Cap/Depr(5y)112.09%
Cap/Sales(3y)13.03%
Cap/Sales(5y)14.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-0.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-231.25%
EPS Next Y48.65%
EPS Next 2Y28.41%
EPS Next 3Y18.62%
EPS Next 5YN/A
Revenue 1Y (TTM)8.42%
Revenue growth 3Y5.61%
Revenue growth 5Y48.11%
Sales Q2Q%28.58%
Revenue Next Year23.73%
Revenue Next 2Y14.22%
Revenue Next 3Y11.45%
Revenue Next 5YN/A
EBIT growth 1Y408.2%
EBIT growth 3Y-49.28%
EBIT growth 5Y9.35%
EBIT Next Year2013.32%
EBIT Next 3Y176.69%
EBIT Next 5YN/A
FCF growth 1Y-135.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-180%
OCF growth 3YN/A
OCF growth 5YN/A

BALLY'S CORP / BALY Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BALLY'S CORP (BALY) stock?

ChartMill assigns a fundamental rating of 2 / 10 to BALY.


Can you provide the valuation status for BALLY'S CORP?

ChartMill assigns a valuation rating of 1 / 10 to BALLY'S CORP (BALY). This can be considered as Overvalued.


Can you provide the profitability details for BALLY'S CORP?

BALLY'S CORP (BALY) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for BALY stock?

The Earnings per Share (EPS) of BALLY'S CORP (BALY) is expected to grow by 48.65% in the next year.


Is the dividend of BALLY'S CORP sustainable?

The dividend rating of BALLY'S CORP (BALY) is 0 / 10 and the dividend payout ratio is 0%.